当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 现金流量表

金陵药业

(000919)

  

流通市值:40.97亿  总市值:43.16亿
流通股本:5.90亿   总股本:6.22亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,600,452,614.2729,440,068.13,266,763,606.342,044,775,478.7
  客户存款和同业存放款项净增加额000-
  向中央银行借款净增加额000-
  向其他金融机构拆入资金净增加额000-
  收到原保险合同保费取得的现金000-
  收到再保险业务现金净额000-
  保户储金及投资款净增加额000-
  收取利息、手续费及佣金的现金000-
  拆入资金净增加额000-
  回购业务资金净增加额000-
  收到的税费返还001,485,559.53-
  收到其他与经营活动有关的现金33,066,122.319,429,576.9746,834,770.4245,914,506.6
  经营活动现金流入的其他项目000-
  经营活动现金流入小计1,633,518,736.5748,869,645.073,315,083,936.292,090,689,985.3
  购买商品、接受劳务支付的现金852,848,358.5387,851,254.71,705,571,789.061,108,216,491.62
  客户贷款及垫款净增加额000-
  存放中央银行和同业款项净增加额000-
  支付原保险合同赔付款项的现金000-
  支付利息、手续费及佣金的现金000-
  支付保单红利的现金000-
  支付给职工以及为职工支付的现金633,074,623.6342,860,248.541,160,060,473.84767,244,978.71
  支付的各项税费50,986,013.919,289,905.9293,523,957.1665,813,821.14
  支付其他与经营活动有关的现金80,765,441.6456,631,559.98201,737,106.58153,390,725.67
  经营活动现金流出的其他项目000-
  经营活动现金流出小计1,617,674,437.64806,632,969.143,160,893,326.642,094,666,017.14
  经营活动产生的现金流量净额15,844,298.86-57,763,324.07154,190,609.65-3,976,031.84
二、投资活动产生的现金流量:
  收回投资收到的现金700,814,282.78415,418,904.13739,900,668.78163,418,006.98
  取得投资收益收到的现金15,979,015.115,824,825.5236,920,174.1211,350,131.5
  处置固定资产、无形资产和其他长期资产收回的现金净额179,351.553,00022,099,980.18807,274.68
  处置子公司及其他营业单位收到的现金净额000-
  收到的其他与投资活动有关的现金000-
  投资活动现金流入小计716,972,649.44421,246,729.65798,920,823.08175,575,413.16
  购建固定资产、无形资产和其他长期资产支付的现金73,335,097.4780,308,521.92201,629,587.48112,194,251.96
  投资支付的现金1,221,200,000759,127,273.671,314,996,143.16771,800,000
  质押贷款净增加额000-
  取得子公司及其他营业单位支付的现金000-
  支付其他与投资活动有关的现金000-
  投资活动现金流出小计1,294,535,097.47839,435,795.591,516,625,730.64883,994,251.96
  投资活动产生的现金流量净额-577,562,448.03-418,189,065.94-717,704,907.56-708,418,838.8
三、筹资活动产生的现金流量:
  吸收投资收到的现金00743,999,998.1742,632,289.33
  其中:子公司吸收少数股东投资收到的现金000-
  取得借款收到的现金00150,000,000-
  收到其他与筹资活动有关的现金000-
  筹资活动现金流入小计00893,999,998.1742,632,289.33
  偿还债务支付的现金000-
  分配股利、利润或偿付利息支付的现金7,522,456.21922,117.2163,336,769.4262,276,801.44
  其中:子公司支付给少数股东的股利、利润1,050,000093,841.6284,348.64
  支付其他与筹资活动有关的现金-024,245,617.11325,000
  筹资活动现金流出小计7,522,456.21922,117.2187,582,386.5362,601,801.44
  筹资活动产生的现金流量净额-7,522,456.21-922,117.21806,417,611.57680,030,487.89
四、汇率变动对现金及现金等价物的影响17,563.957,014.8837,275.3212,403.37
五、现金及现金等价物净增加额-569,223,041.43-476,867,492.34242,940,588.98-32,351,979.38
  加:期初现金及现金等价物余额1,581,367,967.421,581,367,967.421,338,427,378.441,220,402,441.7
  期末现金及现金等价物余额1,012,144,925.991,104,500,475.081,581,367,967.421,188,050,462.32
补充资料:
  净利润50,416,925.32-17,954,033.17-
  资产减值准备1,901,062.12-93,562,882.59-
  固定资产和投资性房地产折旧66,419,150.45-135,627,402.22-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧66,419,150.45-135,627,402.22-
  无形资产摊销9,839,884.56-19,120,147.89-
  长期待摊费用摊销7,142,693.92-8,202,131.37-
  处置固定资产、无形资产和其他长期资产的损失44,966.62--21,343,277.64-
  固定资产报废损失--4,311,147.16-
  公允价值变动损失-12,013,263.09--14,387,532.64-
  财务费用2,556,969-2,744,381.7-
  投资损失-11,824,341.53--39,616,814.17-
  递延所得税1,084,977.7-2,668,509.75-
  其中:递延所得税资产减少34,583.7-4,114,581.31-
    递延所得税负债增加1,050,394--1,446,071.56-
  存货的减少29,396,271.11-18,786,901.7-
  经营性应收项目的减少-48,623,889.31--90,626,687.53-
  经营性应付项目的增加-82,025,756.22-11,011,166.42-
  现金的期末余额1,012,144,925.99-1,581,367,967.42-
  减:现金的期初余额1,581,367,967.42-1,338,427,378.44-
  现金及现金等价物的净增加额-569,223,041.43-242,940,588.98-
公告日期2025-08-282025-04-282025-03-292024-10-29
审计意见(境内)标准无保留意见
TOP↑